Multiple myeloma treated with high dose intravenous melphalan
- 1 May 1987
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 66 (1), 55-62
- https://doi.org/10.1111/j.1365-2141.1987.00045.x-i1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The concept of primingEuropean Journal of Cancer and Clinical Oncology, 1985
- Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in AdultsBritish Journal of Cancer, 1985
- Controversies in the treatment of plasma cell myelomaPublished by Oxford University Press (OUP) ,1985
- High dose melphalan and autologous bone marrow transplantation for solid tumours of childhoodEuropean Paediatric Haematology and Oncology, 1985
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983
- Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantationBritish Journal of Cancer, 1983
- Progress in the treatment of plasma cell myeloma?Journal of Clinical Oncology, 1983
- Treatment of multiple myelomaCancer Treatment Reviews, 1981
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975